INC Research/inVentiv Health rebrands as Syneos Health
After running four months after the completion of the $7.4B merger, INC Research and inVentiv Health finally rename themselves Syneos Health. The company will be traded on Nasdaq under the ticker “SYNH.”
The new name created by branding agency Addison Whitney communicates two parts of information. “Syn” represents the value of synchronizing clinical and commercial capabilities offered by the old INC and inVentiv, respectively, while “neo” champions a new approach to biopharma solutions.
CEO Alistair Macdonald sees the new name as a manifestation of synergies and innovative ways of working at the new company.
